Immune Pharmaceuticals Inc. Announces Pricing Of Public Offering Of Common … – CNNMoney

Immune Pharmaceuticals Inc. Announces Pricing Of Public Offering Of Common …CNNMoneyThe Company is offering 3,450,000 units, with each unit consisting of one share of the Company’s common stock, par value $0.001 per share, and one warrant to purchase 0.25 of a share of the Company’s common stock, at a price to the public of $2.50 […]

Immune Pharmaceuticals Inc. Announces Pricing Of Public Offering Of Common … – CNNMoney Read More »

Immune Pharma (IMNP) Reports Offering Of Common Stock And Warrants – StreetInsider.com (subscription)

Immune Pharma (IMNP) Reports Offering Of Common Stock And WarrantsStreetInsider.com (subscription)Immune Pharmaceuticals Inc. (NASDAQ: IMNP) today announced that it is proposing to offer shares of its common stock and warrants to purchase shares of its common stock in an underwritten, registered public offering. The Company expects to grant the … …read more

Immune Pharma (IMNP) Reports Offering Of Common Stock And Warrants – StreetInsider.com (subscription) Read More »

Immune Pharmaceuticals Inc. Announces Proposed Public Offering Of Common … – DigitalJournal.com

Immune Pharmaceuticals Inc. Announces Proposed Public Offering Of Common …DigitalJournal.comThe Company expects to grant the underwriter of the offering an option to purchase additional shares of common stock and warrants to cover over-allotments, if any. The Company intends to use the net proceeds from the offering primarily for general … and more …read more

Immune Pharmaceuticals Inc. Announces Proposed Public Offering Of Common … – DigitalJournal.com Read More »

Immune Pharmaceuticals Inc. Announces Proposed Public Offering Of Common … – MarketWatch

Immune Pharmaceuticals Inc. Announces Proposed Public Offering Of Common …MarketWatchThe Company expects to grant the underwriter of the offering an option to purchase additional shares of common stock and warrants to cover over-allotments, if any. The Company intends to use the net proceeds from the offering primarily for general … and more …read more

Immune Pharmaceuticals Inc. Announces Proposed Public Offering Of Common … – MarketWatch Read More »

LOGL 10-Q Released for 3rd Quarter 2014 – GlobeNewswire (press release)

LOGL 10-Q Released for 3rd Quarter 2014GlobeNewswire (press release)Further, in exchange for the 600,000,000 warrants to purchase shares of the Company’s common stock held by Hillair, Hillair agreed to purchase 600 shares of convertible preferred stock with a value $1,000 each for a total purchase price of $600,000. and more …read more

LOGL 10-Q Released for 3rd Quarter 2014 – GlobeNewswire (press release) Read More »

From 8-K: Zaza Energy To Issue 787530 Shares Under Settlement Pact, Settles … – Benzinga

From 8-K: Zaza Energy To Issue 787530 Shares Under Settlement Pact, Settles …BenzingaPursuant to the Securities Purchase Agreement, on July 21, 2014, the Company sold warrants to the investor to purchase 361,493 shares of common stock at an exercise price of $11.2036 per share (as adjusted for a 10-for-1 reverse stock split effective … …read

From 8-K: Zaza Energy To Issue 787530 Shares Under Settlement Pact, Settles … – Benzinga Read More »

Applied DNA Sciences Inc. Announces Uplisting to NASDAQ and Pricing of $9.1 … – MarketWatch

Applied DNA Sciences Inc. Announces Uplisting to NASDAQ and Pricing of $9.1 …MarketWatchThe Company also announced the pricing of an underwritten public offering of 2,800,000 shares of common stock, and warrants to purchase up to an aggregate of 2,800,000 shares of common stock, at an offering price of $3.24 per share and $0.01 per …

Applied DNA Sciences Inc. Announces Uplisting to NASDAQ and Pricing of $9.1 … – MarketWatch Read More »

Scroll to Top